(Reuters) - Novo Nordisk said on Wednesday it would discontinue its long-acting insulin Levemir in the United States, citing manufacturing constraints, reduced patient access and available ...

Levemir, one of the three types of long-acting basal insulins, is evacuating the U.S. market, and diabetes patient advocates told USA Today they’re worried about using a new medication after nearly ...

Insulin is an essential medicine that helps the body turn food into energy and regulate blood sugar levels for millions of people with diabetes nationwide. That makes access to insulin vital for ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Store Levemir® FlexPen® that are not being used in the fridge between ...

Levemir (insulin detemir) is a brand-name injection that’s prescribed for diabetes. Levemir has interactions with alcohol, some other drugs, and certain supplements. Examples include beta-blockers and ...

Denmark-based Novo Nordisk is limiting its supply of insulin products, according to the American Society of Health-System Pharmacists’ drug shortage database. The drugmaker is reporting a shortage of ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Novo Nordisk logo above the entrance to their offices in Copenhagen (Reuters) - Novo Nordisk said on Wednesday it ...